Plus Are We About To Lose Every Job To Robots?Like this? Get AIDAILY, delivered to your inbox, 3x a week. Subscribe to our newsletter at https://aidaily.usAI Is Radicalizing Both Sides—Welcome to the New Culture WarAI isn’t just changing tools—it’s fueling a full-blown ideological war. Some see AI as the ultimate evolution of human progress, while skeptics dismiss it as a bubble or worse. The tech’s strengths and flaws—automation, hallucinations, social impact—are driving both hype and backlash. This split isn’t about tech, it’s about belief. Would You Replace Your CEO with an AI Avatar? Tech CEOs Are Testing the WatersSome tech bosses are literally sending AI versions of themselves to earnings calls: Klarna’s Sebastian Siemiatkowski and Zoom’s Eric Yuan let digital avatars do their talking for them. Meanwhile, Klarna's CEO even admitted AI could eventually replace his own job—though real-world chaos means humans aren’t fully out… yet. Winning the AI Race Means More Than Just Tech—The U.S. Needs StrategyThe U.S.–China AI competition isn’t just about building smarter bots—it’s a full-on geopolitical showdown. It’s a race on three fronts: developing AGI, embedding AI across societies, and securing chips, data lanes, and regulation. To stay on top, the U.S. needs a holistic plan that blends innovation, smart policy, and defense—not just private‑sector hype. Left Tech for Welding—Here’s Why It Was the Best Move EverTabby Toney got laid off from her software gig in May and bailed on tech because AI was making everything feel shallow. Instead, she’s welding again—tapping into creativity, problem-solving, and actual hands-on work. No more burnout, no more prep for grueling interviews—just real craft. We’re About to Lose Almost Every Job to Robots—Here’s the DealFuturist Adam Dorr says in the next ~20 years, robots and AI will snatch nearly all jobs—cooking, coding, caring—faster and cheaper than us. Some human roles may hang on, but not nearly enough. Society’s gotta rethink how we share value, income, and purpose before chaos hits. AI That Promises to ‘Solve All Diseases’ Is Heading Into Human TrialsA stealthy Google-owned lab, Isomorphic Labs (spun out from DeepMind), is now testing AI-designed cancer drugs in humans. Backed by AlphaFold 3, it designs molecules in silico, aiming to slash the 10–15 year, billion-dollar drug timeline. But with no clue how the AI makes decisions, questions around safety, transparency, pricing, and monopoly loom large.

Ver todos los episodios